Financial Metrics Unveiled: Revolution Medicines Inc (RVMD)’s Key Ratios in the Spotlight

Kiel Thompson

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

The price of Revolution Medicines Inc (NASDAQ: RVMD) closed at $59.34 in the last session, up 1.31% from day before closing price of $58.57. In other words, the price has increased by $1.31 from its previous closing price. On the day, 2.4 million shares were traded. RVMD stock price reached its highest trading level at $60.0 during the session, while it also had its lowest trading level at $58.0.

Ratios:

We take a closer look at RVMD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.79 and its Current Ratio is at 11.79. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on November 03, 2025, initiated with a Outperform rating and assigned the stock a target price of $77.

On October 21, 2025, Mizuho started tracking the stock assigning a Outperform rating and target price of $90.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 17 ’25 when MARK A GOLDSMITH bought 10,000 shares for $49.68 per share.

JEFFREY TODD CISLINI bought 12,000 shares of RVMD for $596,160 on Oct 17 ’25. On Oct 16 ’25, another insider, MARK A GOLDSMITH, who serves as the Director of the company, bought 10,000 shares for $49.56 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVMD now has a Market Capitalization of 11092615168 and an Enterprise Value of 9088231424.

Stock Price History:

The Beta on a monthly basis for RVMD is 0.99, which has changed by -0.008967876 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, RVMD has reached a high of $62.40, while it has fallen to a 52-week low of $29.17. The 50-Day Moving Average of the stock is 24.38%, while the 200-Day Moving Average is calculated to be 45.08%.

Shares Statistics:

According to the various share statistics, RVMD traded on average about 2.18M shares per day over the past 3-months and 2211050 shares per day over the past 10 days. A total of 186.90M shares are outstanding, with a floating share count of 162.03M. Insiders hold about 13.32% of the company’s shares, while institutions hold 91.69% stake in the company. Shares short for RVMD as of 1760486400 were 19363548 with a Short Ratio of 8.88, compared to 1757894400 on 18053357. Therefore, it implies a Short% of Shares Outstanding of 19363548 and a Short% of Float of 11.020000000000001.

Earnings Estimates

Revolution Medicines Inc (RVMD) is currently under the scrutiny of 16.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$1.52, with high estimates of -$1.18 and low estimates of -$1.73.

Analysts are recommending an EPS of between -$4.47 and -$5.62 for the fiscal current year, implying an average EPS of -$5.32. EPS for the following year is -$5.98, with 17.0 analysts recommending between -$4.47 and -$7.69.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.